If It's COVID, Paxlovid? Studies Suggest a Rethink These Days

(MedPage Today) -- Oral nirmatrelvir-ritonavir (Paxlovid) failed to spare COVID-19-vaccinated individuals from the worst outcomes if they got sick, though it may have helped speed recovery time and cut viral loads, according to two community-based...
Source
MedPage Today
Opens original article in a new tab



